The new European biotech act, announced in Ursula von der Leyen’s political guidelines for 2025, was not included in the Commission work programme published on 11 February, but has recently been announced for early 2026.
News & Trends
Procurar
Recentes
- Guidelines on the best practices for the traceability of medicines in hospital settings
- MDCG 2021-12 Rev.2 FAQ on the European Medical Device Nomenclature (EMDN) Revision 2 – April 2026
- GUIDELINE ON REQUIREMENTS FOR REVISION/RENEWAL OF CERTIFICATES OF SUITABILITY TO THE EUROPEAN PHARMACOPOEIA MONOGRAPHS
- EMA Clinical Data Publication (CDP)
- PLANOS DE CONTINGÊNCIA em Farmacovigilância: “Excelente formação, muito prática”
- Formação CTD MODULO 3 : ” Formação útil, clara e objetiva. Bons exemplos práticos para consolidar os conceitos abordados “
- 📢 EU Releases Updated Borderline & Classification Manual (MDR/IVDR)
- Novo regulamento para notificação de efeitos indesejáveis de produtos cosméticos